# EDGAR Filing Document

**Accession Number:** 0001485894
**File Stem:** 0002071691-25-010063
**Filing Date:** 2025-12
**Character Count:** 25202
**Document Hash:** 5f4bf19e898c2a630b6a9eaeb440303b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002071691-25-010063.hdr.sgml**: 20251229

**ACCESSION NUMBER**: 0002071691-25-010063

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251031

**FILED AS OF DATE**: 20251229

**DATE AS OF CHANGE**: 20251229

**PERIOD START**: 20251031

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** J.P. Morgan Exchange-Traded Fund Trust
- **CENTRAL INDEX KEY:** 0001485894

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-22903
- **FILM NUMBER:** 251606083

**BUSINESS ADDRESS:**
- **STREET 1:** 277 PARK AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10172
- **BUSINESS PHONE:** (800) 480-4111

**MAIL ADDRESS:**
- **STREET 1:** 277 PARK AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10172

## Series and Classes Contracts Data

### JPMorgan Healthcare Leaders ETF (Series ID: S000080528)

| Class ID   | Class Name                      | Ticker Symbol   |
|:---|:---|:---|
| C000243005 | JPMorgan Healthcare Leaders ETF | JDOC            |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** J.P. Morgan Exchange-Traded Fund Trust

- **b. Investment Company Act file number:** 811-22903

- **c. CIK number of Registrant:** 0001485894

- **d. LEI of Registrant:** 5493001E1K1DVWDV2464

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 390 Madison Avenue

  - **City:** New York

  - **State:** NY

  - **Foreign country:** US

  - **Zip / Postal Code:** 10017

  - **Telephone number:** 844-457-6383

**Item A.2. Information about the Series.**

- **a. Name of Series:** JPMorgan Healthcare Leaders ETF

- **b. EDGAR series identifier (if any):** S000080528

- **c. LEI of Series:** 5493000GRVENCXRUA282

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2025-10-31

- **b. Date as of which information is reported:** 2025-10-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $8222464.54

**Total Liabilities:** $4641.03

**Net Assets:** $8217823.51

**Cash Not Reported:** $64449.10

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000243005 | 5.04%                | 1.83%                | 4.48%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $-192077.89              | $556252.70                                 |
| Month 2  | $-32586.91               | $168185.84                                 |
| Month 3  | $15282.82                | $333230.17                                 |

**Designated Index Information**

- **Index Name:** N/A

- **Index Identifier:** N/A

### Schedule of Portfolio Investments

| Name                            | Title                           | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Apogee Therapeutics, Inc.       | Apogee Therapeutics, Inc.       | CUSIP: 03770N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1129 | NS      | $63890.11     | 0.78%             |  |  |  | No            |                  1 | On Loan: No      |
| Ionis Pharmaceuticals, Inc.     | Ionis Pharmaceuticals, Inc.     | CUSIP: 462222100<br>LEI: 549300SI4ZGLG0BLUZ92 | Long             | EC               | CORP              | US        |       898 | NS      | $66721.40     | 0.81%             |  |  |  | No            |                  1 | On Loan: No      |
| Japanese Yen                    | Japanese Yen                    | CUSIP: N/A<br>LEI: N/A                        | Short            | STIV             |  | JP        |        -1 | OU      | $-0.01        | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| Bristol-Myers Squibb Co.        | Bristol-Myers Squibb Co.        | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |      1400 | NS      | $64498.00     | 0.78%             |  |  |  | No            |                  1 | On Loan: No      |
| Waters Corp.                    | Waters Corp.                    | CUSIP: 941848103<br>LEI: 5T547R1474YC9HOD8Q74 | Long             | EC               | CORP              | US        |       118 | NS      | $41252.80     | 0.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co.                 | Eli Lilly & Co.                 | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |       692 | NS      | $597099.12    | 7.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Danaher Corp.                   | Danaher Corp.                   | CUSIP: 235851102<br>LEI: S4BKK9OTCEWQ3YHPFM11 | Long             | EC               | CORP              | US        |      1224 | NS      | $263625.12    | 3.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Stryker Corp.                   | Stryker Corp.                   | CUSIP: 863667101<br>LEI: 5493002F0SC4JTBU5137 | Long             | EC               | CORP              | US        |       522 | NS      | $185957.28    | 2.26%             |  |  |  | No            |                  1 | On Loan: No      |
| Neurocrine Biosciences, Inc.    | Neurocrine Biosciences, Inc.    | CUSIP: 64125C109<br>LEI: 549300FECER0XBN49756 | Long             | EC               | CORP              | US        |       504 | NS      | $72177.84     | 0.88%             |  |  |  | No            |                  1 | On Loan: No      |
| Boston Scientific Corp.         | Boston Scientific Corp.         | CUSIP: 101137107<br>LEI: Y6ZDD9FP4P8JSSJMW954 | Long             | EC               | CORP              | US        |      1854 | NS      | $186734.88    | 2.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Dyne Therapeutics, Inc.         | Dyne Therapeutics, Inc.         | CUSIP: 26818M108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      2574 | NS      | $58120.92     | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Biogen, Inc.                    | Biogen, Inc.                    | CUSIP: 09062X103<br>LEI: W8J5WZB5IY3K0NDQT671 | Long             | EC               | CORP              | US        |       430 | NS      | $66336.10     | 0.81%             |  |  |  | No            |                  1 | On Loan: No      |
| Sanofi SA                       | Sanofi SA                       | CUSIP: N/A<br>LEI: 549300E9PC51EN656011       | Long             | EC               | CORP              | FR        |      1701 | NS      | $172078.00    | 2.09%             |  |  |  | No            |                  2 | On Loan: No      |
| Soleno Therapeutics, Inc.       | Soleno Therapeutics, Inc.       | CUSIP: 834203309<br>LEI: 5493003LCY77N7FXK844 | Long             | EC               | CORP              | US        |       825 | NS      | $55407.00     | 0.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Sartorius AG                    | Sartorius AG (Preference)       | CUSIP: N/A<br>LEI: 529900EQV2DY4FOAMU38       | Long             | EC               | CORP              | DE        |       331 | NS      | $91067.37     | 1.11%             |  |  |  | No            |                  2 | On Loan: No      |
| Genmab A/S                      | Genmab A/S                      | CUSIP: 372303206<br>LEI: 529900MTJPDPE4MHJ122 | Long             | EC               | CORP              | DK        |       754 | NS      | $21571.94     | 0.26%             |  |  |  | No            |                  1 | On Loan: No      |
| EssilorLuxottica SA             | EssilorLuxottica SA             | CUSIP: N/A<br>LEI: 549300M3VH1A3ER1TB49       | Long             | EC               | CORP              | FR        |       557 | NS      | $203983.87    | 2.48%             |  |  |  | No            |                  2 | On Loan: No      |
| Argenx SE                       | Argenx SE                       | CUSIP: N/A<br>LEI: 7245009C5FZE6G9ODQ71       | Long             | EC               | CORP              | NL        |        63 | NS      | $51563.45     | 0.63%             |  |  |  | No            |                  2 | On Loan: No      |
| Revolution Medicines, Inc.      | Revolution Medicines, Inc.      | CUSIP: 76155X100<br>LEI: 549300JU3X0LBCQ65892 | Long             | EC               | CORP              | US        |       895 | NS      | $52661.80     | 0.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson               | Johnson & Johnson               | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |      3446 | NS      | $650846.02    | 7.92%             |  |  |  | No            |                  1 | On Loan: No      |
| Merck & Co., Inc.               | Merck & Co., Inc.               | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |      2413 | NS      | $207469.74    | 2.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Disc Medicine, Inc.             | Disc Medicine, Inc.             | CUSIP: 254604101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       295 | NS      | $25434.90     | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Bio-Techne Corp.                | Bio-Techne Corp.                | CUSIP: 09073M104<br>LEI: 54930073RLKQ51TILZ35 | Long             | EC               | CORP              | US        |       388 | NS      | $24277.16     | 0.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Cytokinetics, Inc.              | Cytokinetics, Inc.              | CUSIP: 23282W605<br>LEI: 549300BE5DY1HW7IHA64 | Long             | EC               | CORP              | US        |       687 | NS      | $43686.33     | 0.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Daiichi Sankyo Co. Ltd.         | Daiichi Sankyo Co. Ltd.         | CUSIP: N/A<br>LEI: 353800XGIU2IHQGC9504       | Long             | EC               | CORP              | JP        |      3300 | NS      | $78830.81     | 0.96%             |  |  |  | No            |                  2 | On Loan: No      |
| Xenon Pharmaceuticals, Inc.     | Xenon Pharmaceuticals, Inc.     | CUSIP: 98420N105<br>LEI: 549300XV44Q9Z1MIPQ03 | Long             | EC               | CORP              | CA        |       796 | NS      | $33368.32     | 0.41%             |  |  |  | No            |                  1 | On Loan: No      |
| Novo Nordisk A/S                | Novo Nordisk A/S, Class B       | CUSIP: N/A<br>LEI: 549300DAQ1CVT6CXN342       | Long             | EC               | CORP              | DK        |      1313 | NS      | $64641.24     | 0.79%             |  |  |  | No            |                  2 | On Loan: No      |
| Ultragenyx Pharmaceutical, Inc. | Ultragenyx Pharmaceutical, Inc. | CUSIP: 90400D108<br>LEI: 529900EV44GVDN1DCX77 | Long             | EC               | CORP              | US        |      1087 | NS      | $37610.20     | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Veeva Systems, Inc.             | Veeva Systems, Inc., Class A    | CUSIP: 922475108<br>LEI: 549300YZEXPDB92M2F02 | Long             | EC               | CORP              | US        |       642 | NS      | $186950.40    | 2.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Danish Krone                    | Danish Krone                    | CUSIP: N/A<br>LEI: N/A                        | Short            | STIV             |  | DK        |        -0 | OU      | $0.00         | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Natera, Inc.                    | Natera, Inc.                    | CUSIP: 632307104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       174 | NS      | $34613.82     | 0.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Swiss Franc                     | Swiss Franc                     | CUSIP: N/A<br>LEI: N/A                        | Long             | STIV             |  | CH        |         0 | OU      | $0.04         | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Exact Sciences Corp.            | Exact Sciences Corp.            | CUSIP: 30063P105<br>LEI: 549300VM3X1FYD4N9Z14 | Long             | EC               | CORP              | US        |       741 | NS      | $47935.29     | 0.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Hoya Corp.                      | Hoya Corp.                      | CUSIP: N/A<br>LEI: 353800X4VR3BHEUCJB42       | Long             | EC               | CORP              | JP        |      1000 | NS      | $162432.11    | 1.98%             |  |  |  | No            |                  2 | On Loan: No      |
| McKesson Corp.                  | McKesson Corp.                  | CUSIP: 58155Q103<br>LEI: 549300WZWOM80UCFSF54 | Long             | EC               | CORP              | US        |       249 | NS      | $202023.66    | 2.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Medtronic plc                   | Medtronic plc                   | CUSIP: N/A<br>LEI: 549300GX3ZBSQWUXY261       | Long             | EC               | CORP              | IE        |      2759 | NS      | $250241.30    | 3.05%             |  |  |  | No            |                  1 | On Loan: No      |
| CG oncology, Inc.               | CG oncology, Inc.               | CUSIP: 156944100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       859 | NS      | $37168.93     | 0.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Argenx SE                       | Argenx SE                       | CUSIP: N/A<br>LEI: 7245009C5FZE6G9ODQ71       | Long             | EC               | CORP              | NL        |       218 | NS      | $178425.90    | 2.17%             |  |  |  | No            |                  2 | On Loan: No      |
| Alnylam Pharmaceuticals, Inc.   | Alnylam Pharmaceuticals, Inc.   | CUSIP: 02043Q107<br>LEI: 529900S3ZI14OWRJII50 | Long             | EC               | CORP              | US        |       119 | NS      | $54268.76     | 0.66%             |  |  |  | No            |                  1 | On Loan: No      |
| Ascendis Pharma A/S             | Ascendis Pharma A/S             | CUSIP: 04351P101<br>LEI: 549300B66JN3W3J8GH73 | Long             | EC               | CORP              | DK        |       301 | NS      | $60681.60     | 0.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Cooper Cos., Inc. (The)         | Cooper Cos., Inc. (The)         | CUSIP: 216648501<br>LEI: QJKMVPIGLH7530PCUE20 | Long             | EC               | CORP              | US        |       969 | NS      | $67742.79     | 0.82%             |  |  |  | No            |                  1 | On Loan: No      |
| Axsome Therapeutics, Inc.       | Axsome Therapeutics, Inc.       | CUSIP: 05464T104<br>LEI: 549300EXGR0XLRJEIB95 | Long             | EC               | CORP              | US        |       409 | NS      | $55210.91     | 0.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Cardinal Health, Inc.           | Cardinal Health, Inc.           | CUSIP: 14149Y108<br>LEI: CCU46N3GJMF4OK4N7U60 | Long             | EC               | CORP              | US        |       728 | NS      | $138880.56    | 1.69%             |  |  |  | No            |                  1 | On Loan: No      |
| Vertex Pharmaceuticals, Inc.    | Vertex Pharmaceuticals, Inc.    | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |       348 | NS      | $148098.36    | 1.80%             |  |  |  | No            |                  1 | On Loan: No      |
| Roche Holding AG                | Roche Holding AG                | CUSIP: N/A<br>LEI: 549300U41AUUVOAAOB37       | Long             | EC               | CORP              | CH        |       437 | NS      | $141553.23    | 1.72%             |  |  |  | No            |                  2 | On Loan: No      |
| Penumbra, Inc.                  | Penumbra, Inc.                  | CUSIP: 70975L107<br>LEI: 549300RGE06P3ECANU72 | Long             | EC               | CORP              | US        |       245 | NS      | $55705.65     | 0.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Cigna Group (The)               | Cigna Group (The)               | CUSIP: 125523100<br>LEI: 549300VIWYMSIGT1U456 | Long             | EC               | CORP              | US        |       176 | NS      | $43016.16     | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Avidity Biosciences, Inc.       | Avidity Biosciences, Inc.       | CUSIP: 05370A108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       783 | NS      | $54692.55     | 0.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Edwards Lifesciences Corp.      | Edwards Lifesciences Corp.      | CUSIP: 28176E108<br>LEI: YA13X31F3V31L8TMPR58 | Long             | EC               | CORP              | US        |      1698 | NS      | $140000.10    | 1.70%             |  |  |  | No            |                  1 | On Loan: No      |
| Genmab A/S                      | Genmab A/S                      | CUSIP: N/A<br>LEI: 529900MTJPDPE4MHJ122       | Long             | EC               | CORP              | DK        |       158 | NS      | $45066.01     | 0.55%             |  |  |  | No            |                  2 | On Loan: No      |
| Convatec Group plc              | Convatec Group plc              | CUSIP: N/A<br>LEI: 213800LS272L4FIDOH92       | Long             | EC               | CORP              | GB        |     16451 | NS      | $52833.78     | 0.64%             |  |  |  | Yes           |                  2 | On Loan: No      |
| Scholar Rock Holding Corp.      | Scholar Rock Holding Corp.      | CUSIP: 80706P103<br>LEI: 549300Z1FLPGL4OWJ459 | Long             | EC               | CORP              | US        |      1021 | NS      | $30242.02     | 0.37%             |  |  |  | No            |                  1 | On Loan: No      |
| IQVIA Holdings, Inc.            | IQVIA Holdings, Inc.            | CUSIP: 46266C105<br>LEI: 549300W3R20NM4KQPH86 | Long             | EC               | CORP              | US        |       550 | NS      | $119053.00    | 1.45%             |  |  |  | No            |                  1 | On Loan: No      |
| AstraZeneca plc                 | AstraZeneca plc                 | CUSIP: N/A<br>LEI: PY6ZZQWO2IZFZC3IOL08       | Long             | EC               | CORP              | GB        |      2268 | NS      | $374103.54    | 4.55%             |  |  |  | No            |                  2 | On Loan: No      |
| Halozyme Therapeutics, Inc.     | Halozyme Therapeutics, Inc.     | CUSIP: 40637H109<br>LEI: 529900242I3SV9AGM753 | Long             | EC               | CORP              | US        |       651 | NS      | $42438.69     | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Fresenius SE & Co. KGaA         | Fresenius SE & Co. KGaA         | CUSIP: N/A<br>LEI: XDFJ0CYCOO1FXRFTQS51       | Long             | EC               | CORP              | DE        |      1822 | NS      | $104843.32    | 1.28%             |  |  |  | No            |                  2 | On Loan: No      |
| Lonza Group AG                  | Lonza Group AG (Registered)     | CUSIP: N/A<br>LEI: 549300EFW4H2TCZ71055       | Long             | EC               | CORP              | CH        |       242 | NS      | $167108.72    | 2.03%             |  |  |  | No            |                  2 | On Loan: No      |
| HCA Healthcare, Inc.            | HCA Healthcare, Inc.            | CUSIP: 40412C101<br>LEI: 529900PH4ZGUH2MNEU89 | Long             | EC               | CORP              | US        |        42 | NS      | $19306.56     | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Intuitive Surgical, Inc.        | Intuitive Surgical, Inc.        | CUSIP: 46120E602<br>LEI: 54930052SRG011710797 | Long             | EC               | CORP              | US        |       237 | NS      | $126624.36    | 1.54%             |  |  |  | No            |                  1 | On Loan: No      |
| AbbVie, Inc.                    | AbbVie, Inc.                    | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |      2445 | NS      | $533107.80    | 6.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |       173 | NS      | $112761.40    | 1.37%             |  |  |  | No            |                  1 | On Loan: No      |
| UnitedHealth Group, Inc.        | UnitedHealth Group, Inc.        | CUSIP: 91324P102<br>LEI: 549300GHBMY8T5GXDE41 | Long             | EC               | CORP              | US        |       769 | NS      | $262659.64    | 3.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Thermo Fisher Scientific, Inc.  | Thermo Fisher Scientific, Inc.  | CUSIP: 883556102<br>LEI: HCHV7422L5HDJZCRFL38 | Long             | EC               | CORP              | US        |       199 | NS      | $112910.61    | 1.37%             |  |  |  | No            |                  1 | On Loan: No      |
| Novartis AG                     | Novartis AG (Registered)        | CUSIP: N/A<br>LEI: 5493007HIVTX6SY6XD66       | Long             | EC               | CORP              | CH        |       680 | NS      | $84157.94     | 1.02%             |  |  |  | No            |                  2 | On Loan: No      |
| EURO                            | EURO                            | CUSIP: N/A<br>LEI: N/A                        | Short            | STIV             |  | XX        |        -0 | OU      | $-0.02        | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| CVS Health Corp.                | CVS Health Corp.                | CUSIP: 126650100<br>LEI: 549300EJG376EN5NQE29 | Long             | EC               | CORP              | US        |      2969 | NS      | $232027.35    | 2.82%             |  |  |  | No            |                  1 | On Loan: No      |
| UCB SA                          | UCB SA                          | CUSIP: N/A<br>LEI: 2138008J191VLSGY5A09       | Long             | EC               | CORP              | BE        |       589 | NS      | $151456.64    | 1.84%             |  |  |  | No            |                  2 | On Loan: No      |
| British Pound                   | British Pound                   | CUSIP: N/A<br>LEI: N/A                        | Long             | STIV             |  | GB        |       230 | OU      | $302.35       | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Align Technology, Inc.          | Align Technology, Inc.          | CUSIP: 016255101<br>LEI: 549300N5YSE0U3LCP840 | Long             | EC               | CORP              | US        |       230 | NS      | $31712.40     | 0.39%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2025-12-01

**Name of Applicant:** J.P. Morgan Exchange-Traded Fund Trust

**Signature:** Timothy J. Clemens

**Name of Signer:** Timothy J. Clemens

**Title:** Treasurer and Principal Financial Officer